Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

The appendix is thought to play a role in all of this by producing inflammatory proteins that trigger the body to produce ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients ...

Although the appendix is generally believed to be a vestigial organ, there is growing evidence pointing to its possible role in modulating gut immunity and microbial homoeostasis.1,2 These roles have ...

Appendicectomy combined with standard medical therapy is superior to standard medical therapy alone in maintaining remission ...

Appendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...

The key distinction among these conditions is in their level of inflammation and potential damage to the digestive tract.

A University of Minnesota research team earned a $11.6 million grant to work with the Mayo Clinic on a device designed to ...

A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

A study published in The Lancet suggests that removing the appendix may reduce the risk of relapse in patients with ulcerative colitis. The research shows a significant reduction in relapse rates and ...

With the introduction of a subcutaneous formulation, ENTYVIO has expanded patient convenience and global accessibility. Continued growth is supported by rising IBD prevalence and ongoing geographic ...